Particle Sciences, Inc. – FDA 483, Jun 24, 2021
An FDA inspection of Lubrizol Life Science Health dba Particles Sciences Inc. in Bethlehem, PA, a sterile drug manufacturer, identified significant deficiencies across multiple areas. The firm was cited for inadequate validation of sterilization processes, unqualified manufacturing equipment, and incomplete investigations into production discrepancies. Additionally, the inspection revealed failures to adhere to written procedures for documentation, product disposition, and the management of stability study samples.
ID · 0f87eece-a9a9-43c5-a2aa-9559e99d83d3
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.